Angiotech Pharmaceuticals is a Vancouver-based pharmaceutical and medical device company founded in 1989. The company focuses on enhancing medical devices and biomaterials through pharmacotherapeutics, with a commitment to developing innovative technologies and medical products for local diseases and complications related to medical devices, surgical procedures, and acute injuries. Angiotech's slogan, "Enhancing the future of healthcare with innovative medical solutions and technologies for local diseases and medical device complications," encapsulates its core mission.
In July 2018, Angiotech secured a Private Equity Round investment from Aretex Capital Partners, underscoring investor confidence in the company's potential for growth and innovation within the Health Care and Medical Devices industries.
